A 30-year-old P1L1 wants contraception for 6 months. She has dhymenorrhea and is a known case of complicated migraine. On USG, the uterus has multiple fibroids. Contraception of choice is:
**Core Concept**
The patient requires a contraceptive method that can manage her menorrhagia, is safe for her complicated migraine, and does not exacerbate her fibroids. This involves choosing a contraceptive method that has anti-progestogenic or progestogenic effects, with minimal androgenic activity, and does not cause significant changes in uterine size or fibroid growth.
**Why the Correct Answer is Right**
The patient is a suitable candidate for a progestin-only contraceptive pill, such as Norgestrel or Levonorgestrel. These pills have a lower risk of exacerbating fibroids and are safer for patients with complicated migraines. The progestin component helps to reduce menstrual bleeding, which would be beneficial for the patient with menorrhagia. Additionally, progestin-only pills are not associated with significant changes in uterine size or fibroid growth.
**Why Each Wrong Option is Incorrect**
**Option A:** Combined oral contraceptives (COCs) are not suitable for this patient due to her complicated migraines. COCs can worsen migraine symptoms and are contraindicated in patients with a history of severe or complicated migraines.
**Option B:** Intrauterine devices (IUDs) are not the best option for this patient, as they may not provide adequate contraception for someone who has multiple fibroids. Additionally, IUDs can cause an increase in uterine size, which may exacerbate fibroid growth.
**Option C:** Depot medroxyprogesterone acetate (DMPA) injections are not the best option for this patient, as they can cause changes in uterine size and potentially exacerbate fibroid growth.
**Clinical Pearl / High-Yield Fact**
For patients with complicated migraines, it's essential to avoid combined hormonal contraceptives and opt for progestin-only methods, which have a lower risk of exacerbating migraine symptoms.
**Correct Answer:** C.